Company Comparison
ContralinePioneering male birth control vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | ContralinePioneering male birth control | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Charlottesville, VA | — |
| Founded | 2015 | — |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $23M | — |
| Valuation | — | — |
What They Build
ContralinePioneering male birth control
Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
ContralinePioneering male birth control
Sector Overlap
Both ContralinePioneering male birth control and 10x Genomics operate in Biotech.
Browse all Biotech companies →